Suchergebnisse - (Person:"De Meyer, Sandra")

PubPharm (19)

1

Virology analysis in HCV genotype 1-infected patients treated with the combination of simeprevir and TMC647055/ritonavir, with and without ribavirin, and JNJ-56914845

enthalten in: Virology journal | 2017

von Vijgen, L. | Thys, K. | Vandebosch, A. | +3

2

In Vitro Activity of Simeprevir against Hepatitis C Virus Genotype 1 Clinical Isolates and Its Correlation with NS3 Sequence and Site-Directed Mutants

enthalten in: Antimicrobial agents and chemotherapy | 2015

von Verbinnen, T. | Fevery, B. | Vijgen, L. | +3

3

Comparison of three quantitative HCV RNA assays in samples from HCV genotype 1- or 4-infected patients treated with the NS3/4A protease inhibitor simeprevir

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2015

von Fevery, B. | Susser, S. | Lenz, O. | +7

4

Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies

enthalten in: Journal of hepatology | 2015

von Lenz, O. | Verbinnen, T. | Fevery, B. | +8

5

Evolution of hepatitis C virus quasispecies during repeated treatment with the NS3/4A protease inhibitor telaprevir

enthalten in: Antimicrobial agents and chemotherapy | 2015

von Susser, S. | Flinders, M. | Reesink, H. | +7

6

An OPTIMIZE study retrospective analysis for management of telaprevir-treated hepatitis C virus (HCV)-infected patients by use of the Abbott RealTime HCV RNA assay

enthalten in: Journal of clinical microbiology | 2015

von Sarrazin, C. | Dierynck, I. | Cloherty, G. | +7

7

Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region

enthalten in: Antiviral research | 2015

von Sarrazin, C. | Lathouwers, E. | Peeters, M. | +11

8

Deep-sequencing analysis of the gene encoding the hepatitis C virus nonstructural 3-4A protease confirms a low prevalence of telaprevir-resistant variants at baseline and the end of the REALIZE study

enthalten in: The Journal of infectious diseases | 2014

von Dierynck, I. | Thys, K. | Ghys, A. | +5

9

Modeling viral evolutionary dynamics after telaprevir-based treatment

enthalten in: PLoS computational biology | 2014

von Haseltine, E. | De Meyer, S. | Dierynck, I. | +9

10

Virologic characterization of genotype 4 hepatitis C virus variants in patients treated with telaprevir

enthalten in: Virology journal | 2014

von De Meyer, S. | Ghys, A. | Dierynck, I. | +3